A herceptin-based chimeric antigen receptor with modified signaling domains leads to enhanced survival of transduced T lymphocytes and antitumor activity

Yangbing Zhao, Qiong J. Wang, Shicheng Yang, James N. Kochenderfer, Zhili Zheng, Xiaosong Zhong, Michel Sadelain, Zelig Eshhar, Steven A. Rosenberg, Richard A. Morgan

Research output: Contribution to journal › Article › peer-review

208 Scopus citations

Fingerprint

Dive into the research topics of 'A herceptin-based chimeric antigen receptor with modified signaling domains leads to enhanced survival of transduced T lymphocytes and antitumor activity'. Together they form a unique fingerprint.

Medicine & Life Sciences